Invasive Prenatal Testing gains momentum through advanced genomics, safer early screening, healthcare investment, and wider access to genetic testing.Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE) -- "Saudi ...

Growth opportunities center on expanded genetic panels, telehealth-enabled regional access, lab automation, awareness campaigns and integration with hospital prenatal care.Dublin, Oct. 07, 2026 (GLOBE ...

Researchers reviewed decades of evidence on fetal DNA to better understand its origins and transport in maternal blood. The ...

The non-invasive pregnancy test (NIPT) has been around since 2011, accessed by millions of women in the intervening years, but how reliable is it? An international team of scientists, led by Adelaide ...

A new case report describes how chromosomal microarray and trio whole-exome sequencing revealed a 10.42 Mb homozygous segment ...

Scientists at Adelaide University revisited years of research on fetal DNA circulation during pregnancy, revealing key ...

Understanding how fetal DNA travels in a pregnant woman's blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances.

"Should I get NIPT?" and "How exactly is it different from amniocentesis?"—consultations regarding prenatal diagnosis are ...

Indentifai Genetics, an Israeli company seeking to commercialise an AI-powered prenatal test, has successfully listed on ...

IdentifaiGenetics (ASX:ID1) started trading on the Australian Securities Exchange on Tuesday after raising AU$10 million in ...

Oguzhan Atay, Chairman and Chief Executive Officer of BillionToOne, Inc. ( BLLN +5.50%), sold 30,331 shares of Class A Common Stock on September 14, 2026, for a total value of ~$3 million, as ...

Evidence highlights the challenges of non-RhD alloimmunization and the limitations of cell-free DNA testing for fetal antigen ...